We are live on ! Find out more
GC

Guggenheim Capital Portfolio holdings

AUM $12.9B
1-Year Est. Return 27.3%
This Fund
S&P 500
This Quarter Est. Return
+5.89%
1 Year Est. Return
+27.3%
3 Year Est. Return
+83.37%
5 Year Est. Return
+104.66%
10 Year Est. Return
+359.15%
AUM
$39.5B
AUM Growth
+$4.37B
Cap. Flow
+$2.48B
Cap. Flow %
6.28%
Top 10 Hldgs %
5.86%
Holding
3,447
New
176
Increased
1,376
Reduced
1,602
Closed
253

Sector Composition

Rank Sector Weight
1 Financials 10.78%
2 Consumer Discretionary 10.44%
3 Technology 10.24%
4 Industrials 10.05%
5 Energy 9.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BEAT
3001
DELISTED
BioTelemetry, Inc.
BEAT
$101K ﹤0.01%
14,057
+2,057
+17% +$16.4K
AT
3002
DELISTED
Atlantic Power Corporation
AT
$100K ﹤0.01%
24,486
-2,374
-9% -$7.74K
UCFC
3003
DELISTED
United Community Financial Corp
UCFC
$100K ﹤0.01%
24,317
-2,326
-9% -$8.63K
SPDC
3004
DELISTED
SPEED COMMERCE, INC COM STK
SPDC
$100K ﹤0.01%
26,618
-1,110
-4% -$3.8K
VG
3005
DELISTED
Vonage Holdings Corporation
VG
$100K ﹤0.01%
26,701
-1,153
-4% -$4.35K
IXP icon
3006
iShares Global Comm Services ETF
IXP
$529M
$98K ﹤0.01%
1,547
-216
-12% -$14.7K
USA icon
3007
Liberty All-Star Equity Fund
USA
$1.79B
$97K ﹤0.01%
16,128
-68,556
-81% -$402K
OCLR
3008
DELISTED
Oclaro Inc.
OCLR
$96K ﹤0.01%
43,527
+7,681
+21% +$19.2K
BGY icon
3009
BlackRock Enhanced International Dividend Trust
BGY
$524M
$95K ﹤0.01%
11,571
SCMP
3010
DELISTED
Sucampo Pharmaceuticals, Inc.
SCMP
$95K ﹤0.01%
13,777
-3,971
-22% -$28.1K
TWGP
3011
DELISTED
TOWER GROUP INTL LTD COM STK (BERMUDA)
TWGP
$95K ﹤0.01%
52,999
-5,288
-9% -$12K
LSTA icon
3012
Lisata Therapeutics
LSTA
$9.02M
$93K ﹤0.01%
96
+15
+19% +$14.6K
VTSS
3013
DELISTED
VITESSE SEMICONDUCTOR CORPORATION COMMON STOCK
VTSS
$92K ﹤0.01%
26,523
+4,626
+21% +$17K
CORR
3014
DELISTED
CorEnergy Infrastructure Trust, Inc.
CORR
$91K ﹤0.01%
2,446
+341
+16% +$12K
CYTR
3015
DELISTED
CytRx Corp
CYTR
$91K ﹤0.01%
3,629
+715
+25% +$16.3K
HCKT icon
3016
Hackett Group
HCKT
$270M
$90K ﹤0.01%
15,009
-993
-6% -$5.98K
SGYP
3017
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
$90K ﹤0.01%
22,182
-1,361
-6% -$5.78K
CPSS icon
3018
Consumer Portfolio Services
CPSS
$202M
$87K ﹤0.01%
11,349
-685
-6% -$5.05K
PSTV icon
3019
Plus Therapeutics
PSTV
$26.6M
0
PCO
3020
DELISTED
Pendrell Corporation - Class A
PCO
$86K ﹤0.01%
49
+7
+17% +$11.6K
XUE
3021
DELISTED
XUEDA EDUCATION GROUP ADS REPTG 2 ORD SHS
XUE
$86K ﹤0.01%
19,279
-942
-5% -$4.69K
SFXE
3022
DELISTED
SFX ENTERTAINMENT, INC COM
SFXE
$85K ﹤0.01%
+10,398
New +$75.7K
CYTK icon
3023
Cytokinetics
CYTK
$10.5B
$84K ﹤0.01%
17,607
-290
-2% -$1.77K
DRRX
3024
DELISTED
DURECT Corp
DRRX
$80K ﹤0.01%
4,411
-441
-9% -$6.19K
PRKR
3025
DELISTED
Parkervision Inc
PRKR
$79K ﹤0.01%
5,321
+241
+5% +$10.8K

Similar funds

Guggenheim Capital's Q2 2014 Portfolio in Review

As of Q2 2014, Guggenheim Capital held 3,447 positions worth $39.5B, up 12% from $35.2B the previous quarter. Its ten largest holdings account for 5.9% of the portfolio.

Guggenheim Capital deployed $2.48B of net new capital in Q2 2014, opening 176 new positions and adding to 1,376 existing holdings. Its largest new stake was DIAMOND RESORTS INTL, INC: 11,338,566 shares worth $264M.

By sector, the portfolio is most concentrated in Financials at 11% of assets, down from 11% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $95.8M trimmed.

  • Guggenheim Capital's largest Q2 2014 buy was DIAMOND RESORTS INTL, INC: 11,338,566 shares worth $264M.
  • Guggenheim Capital added most to Stanley Black & Decker in Q2 2014, an estimated $62.1M increase.
  • Guggenheim Capital's biggest Q2 2014 reduction was iShares Russell 2000 ETF, cutting an estimated $95.8M.
  • Guggenheim Capital fully exited LSI CORPORATION in Q2 2014, selling an estimated $44.6M.
  • Guggenheim Capital's ten largest holdings make up 5.9% of its $39.5B portfolio in Q2 2014.
  • Guggenheim Capital opened 176 new positions and closed 253 in Q2 2014.
  • Guggenheim Capital's portfolio value rose 12% quarter-over-quarter to $39.5B.

Based on Guggenheim Capital's 13F filing for Q2 2014, filed 14 Aug 2014.